Literature DB >> 6539650

Identification of differential drug responses and mechanism(s) of resistance in vincristine-resistant cell lines developed either by exposure to the drug or to fractionated radiation.

B T Hill, R D Whelan, A S Bellamy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6539650     DOI： 10.1016/0305-7372(84)90045-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.

Authors:  W R Waud; S D Harrison; C G Temple; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Experimental and clinical studies alternating chemotherapy and radiotherapy.

Authors:  W B Looney; H A Hopkins; M Tubiana
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

Review 3.  Studies on low-level MDR cells.

Authors:  G Belvedere; E Dolfini
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Cytotoxicity of etretinate and vindesine.

Authors:  J M Gaukroger; L Wilson; R MacKie
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

5.  Establishment of drug resistance in human gastric and colon carcinoma xenograft lines.

Authors:  T Satta; K Isobe; M Yamauchi; I Nakashima; S Akiyama; K Itou; T Watanabe; H Takagi
Journal:  Jpn J Cancer Res       Date:  1991-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.